Radiopharm Theranostics Limited
No trades
Fundamentals and stats
Financial statements, including revenue, expenses, and profit
The total revenue for the last semiannual is 2.25 M AUD, and it's 62.60% higher compared to the previous semiannual. The net income of H2 25 is -17.98 M AUD.
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: AUD
TTM